Additional file 1: of Central nervous system progression in advanced nonâsmall cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study
收藏数据链接：
官方服务：
资源简介：
The raw clinical data of current study. (XLSX 57 kb)
创建时间：
2017-04-05
